Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Cantín A[au]:

Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. Cantin AM et al. J Cyst Fibros. (2015)

Antioxidants and Chronic Obstructive Pulmonary Disease. Vézina FA et al. Chronic Obstr Pulm Dis. (2018)

Risk Factors for Nephrotoxicity Associated with Cisplatin. Almanric K et al. Can J Hosp Pharm. (2017)

Search results

Items: 1 to 50 of 175

1.

Cystic Fibrosis: Pathophysiology of Lung Disease.

Bergeron C, Cantin AM.

Semin Respir Crit Care Med. 2019 Oct 28. doi: 10.1055/s-0039-1694021. [Epub ahead of print]

PMID:
31659725
2.

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome.

Cantin AM.

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1335-1337. doi: 10.1164/rccm.201908-1558ED. No abstract available.

3.

The Pseudomonas aeruginosa Population among Cystic Fibrosis Patients in Quebec, Canada: a Disease Hot Spot without Known Epidemic Isolates.

Jeukens J, Freschi L, Kukavica-Ibrulj I, Emond-Rheault JG, Allard C, Barbeau J, Cantin A, Charette SJ, Déziel E, Malouin F, Milot J, Nguyen D, Popa C, Boyle B, Levesque RC.

J Clin Microbiol. 2019 May 24;57(6). pii: e02019-18. doi: 10.1128/JCM.02019-18. Print 2019 Jun. No abstract available.

4.

Antioxidants and Chronic Obstructive Pulmonary Disease.

Vézina FA, Cantin AM.

Chronic Obstr Pulm Dis. 2018 Oct 8;5(4):277-288. doi: 10.15326/jcopdf.5.4.2018.0133.

5.

Chiral hybrid materials based on pyrrolidine building units to perform asymmetric Michael additions with high stereocontrol.

Llopis S, García T, Cantín Á, Velty A, Díaz U, Corma A.

Catal Sci Technol. 2018 Nov 21;8(22):5835-5847. doi: 10.1039/c8cy01650j. Epub 2018 Oct 23.

6.

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.

Khalil N, Manganas H, Ryerson CJ, Shapera S, Cantin AM, Hernandez P, Turcotte EE, Parker JM, Moran JE, Albert GR, Sawtell R, Hagerimana A, Laurin P, Gagnon L, Cesari F, Kolb M.

Eur Respir J. 2019 Mar 18;53(3). pii: 1800663. doi: 10.1183/13993003.00663-2018. Print 2019 Mar.

7.

Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network.

Chartrand M, Lalonde L, Cantin A, Lahaie A, Odobasic B, Tremblay MP, Wazzan D, Gagnon MM, Martin É, Dorais M, Berbiche D, Guénette L.

J Clin Pharm Ther. 2018 Dec;43(6):877-887. doi: 10.1111/jcpt.12745. Epub 2018 Jul 17.

PMID:
30019341
8.

F508del-CFTR is not corrected by thymosin α1.

Matthes E, Hanrahan JW, Cantin AM.

Nat Med. 2018 Jul;24(7):890-891. doi: 10.1038/s41591-018-0079-6. No abstract available.

PMID:
29942095
9.

The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.

Morin C, Cantin AM, Vézina FA, Fortin S.

Mar Drugs. 2018 May 26;16(6). pii: E184. doi: 10.3390/md16060184.

10.

Low-Hanging Fruit and Antioxidant Therapy in Cystic Fibrosis.

Cantin AM.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):555-557. doi: 10.1164/rccm.201805-0872ED. No abstract available.

PMID:
29847144
11.

Nebulized heparin and N-acetylcysteine for smoke inhalational injury: A case report.

Ashraf U, Bajantri B, Roa-Gomez G, Venkatram S, Cantin A, Diaz-Fuentes G.

Medicine (Baltimore). 2018 May;97(19):e0638. doi: 10.1097/MD.0000000000010638.

12.

Habitat availability and ontogenetic shifts alter bottlenecks in size-structured fish populations.

Cantin A, Post JR.

Ecology. 2018 Jul;99(7):1644-1659. doi: 10.1002/ecy.2371. Epub 2018 Jun 12.

PMID:
29705987
13.

Synthesis and structure determination via ultra-fast electron diffraction of the new microporous zeolitic germanosilicate ITQ-62.

Bieseki L, Simancas R, Jordá JL, Bereciartua PJ, Cantín Á, Simancas J, Pergher SB, Valencia S, Rey F, Corma A.

Chem Commun (Camb). 2018 Feb 22;54(17):2122-2125. doi: 10.1039/c7cc09240g.

PMID:
29419825
14.

Control of zeolite framework flexibility and pore topology for separation of ethane and ethylene.

Bereciartua PJ, Cantín Á, Corma A, Jordá JL, Palomino M, Rey F, Valencia S, Corcoran EW Jr, Kortunov P, Ravikovitch PI, Burton A, Yoon C, Wang Y, Paur C, Guzman J, Bishop AR, Casty GL.

Science. 2017 Nov 24;358(6366):1068-1071. doi: 10.1126/science.aao0092.

PMID:
29170235
15.

Cigarette smoke activates CFTR through ROS-stimulated cAMP signaling in human bronchial epithelial cells.

Wong FH, AbuArish A, Matthes E, Turner MJ, Greene LE, Cloutier A, Robert R, Thomas DY, Cosa G, Cantin AM, Hanrahan JW.

Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C118-C134. doi: 10.1152/ajpcell.00099.2017. Epub 2017 Oct 4.

16.

Risk Factors for Nephrotoxicity Associated with Cisplatin.

Almanric K, Marceau N, Cantin A, Bertin É.

Can J Hosp Pharm. 2017 Mar-Apr;70(2):99-106. Epub 2017 Apr 28.

17.

Thymosin α1: a single drug with multiple targets in cystic fibrosis.

Cantin AM, Hanrahan JW.

Nat Med. 2017 May 5;23(5):536-538. doi: 10.1038/nm.4339. No abstract available.

PMID:
28475572
18.

Synthesis and Characterization of a Phosphate Prodrug of Isoliquiritigenin.

Boyapelly K, Bonin MA, Traboulsi H, Cloutier A, Phaneuf SC, Fortin D, Cantin AM, Richter MV, Marsault E.

J Nat Prod. 2017 Apr 28;80(4):879-886. doi: 10.1021/acs.jnatprod.6b00600. Epub 2017 Mar 2.

PMID:
28252963
19.
20.

Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception.

Cantin A, Lahaie A, Odobasic B, Tremblay MP, Wazzan D, Caron S, Leblanc C, Martineau J, Lalonde L.

Can Pharm J (Ott). 2016 Nov;149(6):352-361. Epub 2016 Oct 6.

21.

Interaction of ecological and angler processes: experimental stocking in an open access, spatially structured fishery.

Mee JA, Post JR, Ward H, Wilson KL, Newton E, Cantin A.

Ecol Appl. 2016 Sep;26(6):1693-1707. doi: 10.1890/15-0879.1.

PMID:
27755695
22.

Bis-Michael Acceptors as Novel Probes to Study the Keap1/Nrf2/ARE Pathway.

Deny LJ, Traboulsi H, Cantin AM, Marsault É, Richter MV, Bélanger G.

J Med Chem. 2016 Oct 27;59(20):9431-9442. Epub 2016 Oct 5.

PMID:
27682717
23.

Supply-demand equilibria and the size-number trade-off in spatially structured recreational fisheries.

Wilson KL, Cantin A, Ward HG, Newton ER, Mee JA, Varkey DA, Parkinson EA, Post JR.

Ecol Appl. 2016 Jun;26(4):1086-97.

PMID:
27509750
24.

Cystic Fibrosis Transmembrane Conductance Regulator. Implications in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Cantin AM.

Ann Am Thorac Soc. 2016 Apr;13 Suppl 2:S150-5. doi: 10.1513/AnnalsATS.201509-588KV. Review.

PMID:
27115950
25.

A Word from the Scientific Committee. 14th Gordon L. Snider Critical Issues Workshop.

Wanner A, Boucher R, Cantin A, Kelsen S.

Ann Am Thorac Soc. 2016 Apr;13 Suppl 2:S111. doi: 10.1513/AnnalsATS.201504-247KV. No abstract available.

PMID:
27115942
26.

Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.

Cantin A, Gingras L, Lachance B, Foster W, Goudreault J, Archambault L.

Med Phys. 2015 Dec;42(12):7011-21. doi: 10.1118/1.4935529.

PMID:
26632056
27.

Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.

Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Laroche J, Larose S, Maaroufi H, Fothergill JL, Moore M, Winsor GL, Aaron SD, Barbeau J, Bell SC, Burns JL, Camara M, Cantin A, Charette SJ, Dewar K, Déziel É, Grimwood K, Hancock RE, Harrison JJ, Heeb S, Jelsbak L, Jia B, Kenna DT, Kidd TJ, Klockgether J, Lam JS, Lamont IL, Lewenza S, Loman N, Malouin F, Manos J, McArthur AG, McKeown J, Milot J, Naghra H, Nguyen D, Pereira SK, Perron GG, Pirnay JP, Rainey PB, Rousseau S, Santos PM, Stephenson A, Taylor V, Turton JF, Waglechner N, Williams P, Thrane SW, Wright GD, Brinkman FS, Tucker NP, Tümmler B, Winstanley C, Levesque RC.

Front Microbiol. 2015 Sep 29;6:1036. doi: 10.3389/fmicb.2015.01036. eCollection 2015.

28.

Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions.

Boulanger S, Mitchell G, Bouarab K, Marsault É, Cantin A, Frost EH, Déziel E, Malouin F.

Antimicrob Agents Chemother. 2015 Dec;59(12):7458-64. doi: 10.1128/AAC.01711-15. Epub 2015 Sep 21.

29.

The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.

Traboulsi H, Cloutier A, Boyapelly K, Bonin MA, Marsault É, Cantin AM, Richter MV.

Antimicrob Agents Chemother. 2015 Oct;59(10):6317-27. doi: 10.1128/AAC.01098-15. Epub 2015 Jul 27.

30.

Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.

Torphy TJ, Allen J, Cantin AM, Konstan MW, Accurso FJ, Joseloff E, Ratjen FA, Chmiel JF; Antiinflammatory Therapy Working Group.

Ann Am Thorac Soc. 2015 Sep;12(9):1398-406. doi: 10.1513/AnnalsATS.201506-361OT. Review.

PMID:
26146892
31.

Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.

Cantin AM, Hartl D, Konstan MW, Chmiel JF.

J Cyst Fibros. 2015 Jul;14(4):419-30. doi: 10.1016/j.jcf.2015.03.003. Epub 2015 Mar 23. Review.

32.

Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis.

Morin C, Cantin AM, Rousseau É, Sirois M, Sirois C, Rizcallah E, Fortin S.

Am J Respir Cell Mol Biol. 2015 Oct;53(4):574-83. doi: 10.1165/rcmb.2014-0223OC.

PMID:
25781052
33.

The first zeolite with a tri-directional extra-large 14-ring pore system derived using a phosphonium-based organic molecule.

Yun Y, Hernández M, Wan W, Zou X, Jordá JL, Cantín A, Rey F, Corma A.

Chem Commun (Camb). 2015 May 4;51(36):7602-5. doi: 10.1039/c4cc10317c.

PMID:
25697962
34.

Inhibition of influenza virus replication by targeting broad host cell pathways.

Marois I, Cloutier A, Meunier I, Weingartl HM, Cantin AM, Richter MV.

PLoS One. 2014 Oct 21;9(10):e110631. doi: 10.1371/journal.pone.0110631. eCollection 2014.

35.

Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.

Fugère A, Lalonde Séguin D, Mitchell G, Déziel E, Dekimpe V, Cantin AM, Frost E, Malouin F.

PLoS One. 2014 Jan 23;9(1):e86705. doi: 10.1371/journal.pone.0086705. eCollection 2014.

36.

A new microporous zeolitic silicoborate (ITQ-52) with interconnected small and medium pores.

Simancas R, Jordá JL, Rey F, Corma A, Cantín A, Peral I, Popescu C.

J Am Chem Soc. 2014 Mar 5;136(9):3342-5. doi: 10.1021/ja411915c. Epub 2014 Feb 19.

PMID:
24456134
37.

MAG-EPA resolves lung inflammation in an allergic model of asthma.

Morin C, Fortin S, Cantin AM, Rousseau É.

Clin Exp Allergy. 2013 Sep;43(9):1071-82. doi: 10.1111/cea.12162.

PMID:
23957343
38.

SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants.

Mitchell G, Fugère A, Pépin Gaudreau K, Brouillette E, Frost EH, Cantin AM, Malouin F.

PLoS One. 2013 May 21;8(5):e65018. doi: 10.1371/journal.pone.0065018. Print 2013.

39.

Regulated proteolysis of a transcription factor complex is critical to cell cycle progression in Caulobacter crescentus.

Gora KG, Cantin A, Wohlever M, Joshi KK, Perchuk BS, Chien P, Laub MT.

Mol Microbiol. 2013 Mar;87(6):1277-89. doi: 10.1111/mmi.12166. Epub 2013 Feb 25.

40.

Anti-cancer effects of a new docosahexaenoic acid monoacylglyceride in lung adenocarcinoma.

Morin C, Fortin S, Cantin AM, Sirois M, Sirois C, Rizcallah E, Rousseau É.

Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):319-34.

PMID:
23092161
41.

Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.

Bossé D, Lemire C, Ruel J, Cantin AM, Ménard F, Valiquette L.

Infection. 2013 Apr;41(2):579-82. doi: 10.1007/s15010-012-0328-4. Epub 2012 Sep 21.

PMID:
22996384
42.

Plasma biomarkers and cystic fibrosis lung disease.

Cantin AM, Bilodeau G, Larivée P, Richter MV.

Clin Invest Med. 2012 Jul 4;35(4):E173-81.

PMID:
22863555
43.

Cigarette smoke-induced proteostasis imbalance in obstructive lung diseases.

Cantin AM, Richter MV.

Curr Mol Med. 2012 Aug;12(7):836-49. Review.

PMID:
22697342
44.

New insight into the transcarbamylase family: the structure of putrescine transcarbamylase, a key catalyst for fermentative utilization of agmatine.

Polo LM, Gil-Ortiz F, Cantín A, Rubio V.

PLoS One. 2012;7(2):e31528. doi: 10.1371/journal.pone.0031528. Epub 2012 Feb 20.

45.

The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection.

Cloutier A, Marois I, Cloutier D, Verreault C, Cantin AM, Richter MV.

J Infect Dis. 2012 Feb 15;205(4):621-30. doi: 10.1093/infdis/jir804. Epub 2012 Jan 4.

PMID:
22219346
47.

Development and validation of a high-throughput screening assay for the hepatitis C virus p7 viroporin.

Gervais C, Dô F, Cantin A, Kukolj G, White PW, Gauthier A, Vaillancourt FH.

J Biomol Screen. 2011 Mar;16(3):363-9. doi: 10.1177/1087057110396215. Epub 2011 Feb 22.

PMID:
21343600
48.

Cystic fibrosis: an-ion transport issue?

Pier G, Prince A, Cantin A.

Nat Med. 2011 Feb;17(2):166-7. doi: 10.1038/nm0211-166. No abstract available.

49.

Modular organic structure-directing agents for the synthesis of zeolites.

Simancas R, Dari D, Velamazán N, Navarro MT, Cantín A, Jordá JL, Sastre G, Corma A, Rey F.

Science. 2010 Nov 26;330(6008):1219-22. doi: 10.1126/science.1196240.

50.

Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma.

Morin C, Fortin S, Cantin AM, Rousseau E.

Am J Respir Cell Mol Biol. 2011 Aug;45(2):366-75. doi: 10.1165/rcmb.2010-0156OC. Epub 2010 Nov 5.

PMID:
21057106

Supplemental Content

Loading ...
Support Center